Retroviral expression of a kinase-defective IGF-I receptor suppresses growth and causes apoptosis of CHO and U87 cells in-vivo

被引:23
作者
Seely, BL
Samimi, G
Webster, NJG [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[3] San Diego Vet Affairs Healthcare Syst, Med Res Serv, La Jolla, CA 92161 USA
关键词
D O I
10.1186/1471-2407-2-15
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Phosphatidylinositol- 3, 4, 5-triphosphate (PtdInsP3) signaling is elevated in many tumors due to loss of the tumor suppressor PTEN, and leads to constitutive activation of Akt, a kinase involved in cell survival. Reintroduction of PTEN in cells suppresses transformation and tumorigenicity. While this approach works in-vitro, it may prove difficult to achieve in-vivo. In this study, we investigated whether inhibition of growth factor signaling would have the same effect as re-expression of PTEN. Methods: Dominant negative IGF-I receptors were expressed in CHO and U87 cells by retroviral infection. Cell proliferation, transformation and tumor formation in athymic nude mice were assessed. Results: Inhibition of IGF-IR signaling in a CHO cell model system by expression of a kinase-defective IGF-IR impairs proliferation, transformation and tumor growth. Reduction in tumor growth is associated with an increase in apoptosis in-vivo. The dominant-negative IGF-IRs also prevented growth of U87 PTEN-negative glioblastoma cells when injected into nude mice. Injection of an IGF-IR blocking antibody alphaIR3 into mice harboring parental U87 tumors inhibits tumor growth and increases apoptosis. Conclusion: Inhibition of an upstream growth factor signal prevents tumor growth of the U87 PTEN-deficient glioma to the same extent as re-introduction of PTEN. This result suggests that growth factor receptor inhibition may be an effective alternative therapy for PTEN-deficient tumors.
引用
收藏
页数:9
相关论文
共 58 条
  • [1] Accili D, 1999, J PEDIATR ENDOCR MET, V12, P475
  • [2] Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity
    Ali, IU
    Schriml, LM
    Dean, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (22): : 1922 - 1932
  • [3] Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
    Andrews, DW
    Resnicoff, M
    Flanders, AE
    Kenyon, L
    Curtis, M
    Merli, G
    Baserga, R
    Iliakis, G
    Aiken, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2189 - 2200
  • [4] [Anonymous], 1997, BIOCH BIOPHYSICA ACT
  • [5] EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II AND THEIR RECEPTOR MESSENGER-RNAS IN PRIMARY HUMAN ASTROCYTOMAS AND MENINGIOMAS - INVIVO STUDIES USING INSITU HYBRIDIZATION AND IMMUNOCYTOCHEMISTRY
    ANTONIADES, HN
    GALANOPOULOS, T
    NEVILLEGOLDEN, J
    MAXWELL, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (02) : 215 - 222
  • [6] BLOCKADE OF THE TYPE-I SOMATOMEDIN RECEPTOR INHIBITS GROWTH OF HUMAN-BREAST CANCER-CELLS IN ATHYMIC MICE
    ARTEAGA, CL
    KITTEN, LJ
    CORONADO, EB
    JACOBS, S
    KULL, FC
    ALLRED, DC
    OSBORNE, CK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) : 1418 - 1423
  • [7] BASERGA R, 1995, CANCER RES, V55, P249
  • [8] The IGF-I receptor in cancer research
    Baserga, R
    [J]. EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) : 1 - 6
  • [9] The IGF-I receptor and cancer
    Baserga, R
    Resnicoff, M
    Dews, M
    [J]. ENDOCRINE, 1997, 7 (01) : 99 - 102
  • [10] MUTANT IGF-I RECEPTORS AS DOMINANT NEGATIVES FOR GROWTH AND TRANSFORMATION
    BURGAUD, JL
    RESNICOFF, M
    BASERGA, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (02) : 475 - 481